Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes

Author： Marastoni M.   Bazzaro M.   Bortolotti F.   Salvadori S.   Tomatis R.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.34, Iss.7, 1999-07, pp. : 651-657

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Discovery of Novel Histone Lysine Methyltransferase G9a Inhibitors (Part 1): Molecular Design Based on a Series of Substituted 2,4-Diamino-7- aminoalkoxyquinazoline by Molecular-Docking-Guided 3D Quantitative Structure-Activity Relationship Studies

By  

Medicinal Chemistry, Vol. 10, Iss. 4, 2014-04 ,pp. : 426-440

Bentham Science Publishers

Access to resources Recommend Favorite

Hologram Quantitative Structure-Activity Relationships for a Class of Inhibitors of HIV-1 Protease

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 5, 2007-07 ,pp. : 356-364

Bentham Science Publishers

Access to resources Recommend Favorite

Structure Based Design of Inhibitors of Aspartic Protease of HIV-1

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 8, 2005-12 ,pp. : 638-646

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and Structure-Activity Relationship Studies of Novel 4 (1-adamantyl) Phenyl Analogues as HIF-1 Inhibitors

By  

Medicinal Chemistry, Vol. 12, Iss. 4, 2016-06 ,pp. : 338-346

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-activity relationships of first bishydroxymethyl-substituted cage dimeric 4-aryl-1,4-dihydropyridines as HIV-1 protease inhibitors

By Hilgeroth A.   Lilie H.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 5, 2003-05 ,pp. : 495-499

Elsevier

Access to resources Recommend Favorite